| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
-Subunit Secretion1
Departments of Endocrinology (M.K., A.G., G.M.B., J.P.M.), Clinical Biochemistry (R.H.S., J.M.B.), and Morbid Anatomy (J.F.G.), St. Bartholomews and the Royal London School of Medicine and Dentistry, London, United Kingdom E1 2AD
Address all correspondence and requests for reprints to: Dr. R. H. Skelly, Clinical Biochemistry, St. Bartholomews and Royal London School of Medicine and Dentistry, Turner Street, London, United Kingdom E1 2AD. E-mail: r.h.skelly{at}mds.qmw.ac.uk
We have studied the expression of the pituitary transcription factors
Ptx-1 and Prop-1 in a series of 34 pituitary adenomas fully
characterized for in vitro hormone secretion and
histological staining. In studies involving mammalian cell lines, the
pituitary transcription factor Ptx-1 has been shown to be a pituitary
hormone panactivator, whereas more recent studies have shown that it
plays an important role in
-subunit gene expression. Its expression
has not been examined previously in human pituitary adenomas
characterized by in vitro hormone secretory profiles. Of
the 34 pituitary adenomas studied, Ptx-1 expression was reduced by more
than 50% compared to that of the housekeeping gene human
glyceraldehyde-3-phosphate dehydrogenase in the 6 corticotroph
adenomas, which also had significantly reduced
-subunit production
(all 6 tumors secreting
0.5 ng/24 h). Mutations of the pituitary
transcription factor Prop-1, which is responsible for the syndrome of
Ames dwarfism in mice, are being increasingly recognized as a cause of
combined pituitary hormone deficiency in humans, although ACTH
deficiency has been described only once. Prop-1 expression was detected
in all 34 pituitary adenomas, including 6 corticotroph adenomas and 5
gonadotroph adenomas. The expression of Prop-1 has not been described
previously in these cell phenotypes.
This article has been cited by other articles:
![]() |
R. D. Ward, B. M. Stone, L. T. Raetzman, and S. A. Camper Cell Proliferation and Vascularization in Mouse Models of Pituitary Hormone Deficiency Mol. Endocrinol., June 1, 2006; 20(6): 1378 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J. F. W. Weigel, A. Keller, W. Hirsch, W. Kiess, W. F. Blum, and R. W. Pfaffle PROP1 Mutations Cause Progressive Deterioration of Anterior Pituitary Function including Adrenal Insufficiency: A Longitudinal Analysis J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5256 - 5265. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Cushman, D. E. Watkins-Chow, M. L. Brinkmeier, L. T. Raetzman, A. L. Radak, R. V. Lloyd, and S. A. Camper Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility Hum. Mol. Genet., May 1, 2001; 10(11): 1141 - 1153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |